Latest News and Press Releases

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of EpCAM-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Her3-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of c-Met-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...

LOUISVILLE, Ky., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Bayer Pharmaceuticals for...

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Oncology Collaboration and Licensing Deals 2020-2025" has been added to ResearchAndMarkets.com's offering.Fully revised and updated, the report...

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Oncology Adjuvants Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The oncology adjuvants market size has grown...

Chicago, IL, Nov. 04, 2025 (GLOBE NEWSWIRE) -- PersonaDx, a precision diagnostic oncology company transforming how metastatic cancers are classified and treated, announced today that its co-founder...

Data from leading healthcare centers reinforce high diagnostic accuracy, workflow efficiency, and cost-effectiveness of Noah Medical's Galaxy System.

FDA has approved Junshi Biosciences' IND for a Phase 2/3 clinical study of JS207 (PD-1/VEGF), for the neoadjuvant treatment of NSCLC